Nutex Health Inc. — Earnings Quality Grade B
NUTX · Healthcare
Generally healthy
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 136 days, change -44 days YoY
AR growth 37.9% vs revenue growth 82.4%
Revenue 82.4%, CFFO 971.7%. Cash follows revenue
Expense Quality
Inventory 0.6% vs COGS 51.9%. Normal
CapEx growth 9.6% vs revenue 82.4%. Normal
SG&A/Gross Profit = 38.0%. Normal
Gross margin swung +9.9pp (40.9% → 50.8%)
Cash Flow Quality
CFFO/NI = 3.51. Profits backed by cash
FCF $0.2B, FCF/NI = 3.47
Accruals ratio = -19.3%. Low accruals
Cash $0.2B covers 53% of debt $0.4B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 11% of equity. Manageable
Debt/EBITDA = 1.2x. Healthy
Other assets -6.9% vs revenue 82.4%. Normal
Write-offs normal
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change 19% YoY. Normal
Manipulation Score
M-Score = -3.13 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25